Skip to content

Biohaven BHVN Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$102.3M-57.3%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$19.86M+17.5%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$125.7M-3.9%
uniQure logo
uniQureQURE
-$53.54M-22.7%
Roivant Sciences logo
Roivant SciencesROIV
-$265.89M-257%

Segments

By segment

See full
Reportable Segment-$130.53M+41.1%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's net income?
Biohaven (BHVN) reported net income of -$130.53M in Q1 2026.
How has Biohaven's net income changed year-over-year?
Biohaven's net income increased by 41.1% year-over-year, from -$221.68M to -$130.53M.
What is the long-term trend for Biohaven's net income?
Over 4 years (2021 to 2025), Biohaven's net income has grown at a 36.3% compound annual growth rate (CAGR), from -$213.8M to -$738.82M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.